Uniphar (LON:UPR) Reaches New 12-Month High – Should You Buy?

Uniphar plc (LON:UPRGet Free Report) hit a new 52-week high on Tuesday . The stock traded as high as GBX 368 and last traded at GBX 368, with a volume of 33264 shares traded. The stock had previously closed at GBX 348.

Uniphar Trading Up 5.7%

The firm’s fifty day moving average price is GBX 320.73 and its 200-day moving average price is GBX 330.43. The company has a market cap of £955.23 million, a price-to-earnings ratio of 15.02 and a beta of 0.75. The company has a debt-to-equity ratio of 119.48, a current ratio of 0.90 and a quick ratio of 0.60.

Insider Activity

In related news, insider Gerard Rabbette sold 43,355 shares of the stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of GBX 362, for a total value of £156,945.10. Corporate insiders own 7.65% of the company’s stock.

Uniphar Company Profile

(Get Free Report)

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.

Featured Articles

Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.